Awarded
Olmesartan+Amlodipin+Hydrochlorothiazid
- Winners
- AbZ-Pharma GmbH (BG TEVA ratiopharm GbR)), Glenmark Arzneimittel GmbH, Heumann Pharma GmbH & Co. Generica KG (BG Heumann / Heunet GbR), Heunet Pharma GmbH (BG Heumann / Heunet GbR), Macleods Pharma Espana, S.L.U, ratiopharm GmbH (BG TEVA ratiopharm GbR)), TEVA GmbH (BG TEVA ratiopharm GbR))
- Contract value
- no value published
- Bids received
- 7
- Published
- 22 May 2026
- Awarded
- 31 Mar 2026
- Contract start
- 31 Mar 2026